Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Tax Provisions (2018 - 2025)

AVITA Medical's Tax Provisions history spans 8 years, with the latest figure at -$17000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 189.47% year-over-year to -$17000.0; the TTM value through Dec 2025 reached $10000.0, down 81.48%, while the annual FY2025 figure was $11000.0, 79.63% down from the prior year.
  • Tax Provisions reached -$17000.0 in Q4 2025 per RCEL's latest filing, down from $15000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $33000.0 in Q2 2024 to a low of -$28000.0 in Q3 2024.
  • Average Tax Provisions over 5 years is $9947.4, with a median of $10000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: surged 650.0% in 2023, then plummeted 354.55% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $6000.0 in 2021, then soared by 300.0% to $24000.0 in 2022, then crashed by 50.0% to $12000.0 in 2023, then surged by 58.33% to $19000.0 in 2024, then tumbled by 189.47% to -$17000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Tax Provisions are -$17000.0 (Q4 2025), $15000.0 (Q3 2025), and $4000.0 (Q2 2025).